Table 3.
Effect of smoking habit change with and without fasting serum glucose elevation on cardiovascular disease-related death.
Continual smokers | Quitters | Ex-smokers | Never smokers | ||
---|---|---|---|---|---|
Cardiovascular disease-related death | Without FSG elevation* | ||||
Events | 133 | 34 | 72 | 127 | |
Person-years | 194,009 | 58,546 | 114,444 | 206,670 | |
aHR (95% CI) | 1.00 (reference) | 0.74 (0.51–1.09) | 0.68 (0.50–0.91) | 0.59 (0.46–0.76) | |
With FSG elevation | |||||
Events | 120 | 30 | 42 | 100 | |
Person-years | 146,281 | 46,952 | 80,915 | 146,282 | |
aHR (95% CI) | 1.00 (reference) | 0.68 (0.46–1.03) | 0.49 (0.34–0.70) | 0.58 (0.44–0.77) | |
Myocardial infarction-related death | Without FSG elevation | ||||
Events | 68 | 16 | 33 | 51 | |
Person-years | 194,009 | 58,546 | 114,444 | 206,670 | |
aHR (95% CI) | 1.00 (reference) | 0.68 (0.39–1.18) | 0.67 (0.44–1.03) | 0.50 (0.34–0.73) | |
With FSG elevation | |||||
Events | 59 | 6 | 20 | 29 | |
Person-years | 146,281 | 46,952 | 80,915 | 146,282 | |
aHR (95% CI) | 1.00 (reference) | 0.26 (0.11–0.62) | 0.50 (0.30–0.84) | 0.36 (0.22–0.57) | |
Total stroke-related death | Without FSG elevation | ||||
Events | 65 | 18 | 39 | 76 | |
Person-years | 194,009 | 58,546 | 114,444 | 206,670 | |
aHR (95% CI) | 1.00 (reference) | 0.80 (0.47–1.35) | 0.69 (0.46–1.03) | 0.68 (0.48–0.96) | |
With FSG elevation | |||||
Events | 61 | 24 | 22 | 71 | |
Person-years | 146,281 | 46,952 | 80,915 | 146,282 | |
aHR (95% CI) | 1.00 (reference) | 1.11 (0.69–1.80) | 0.48 (0.29–0.79) | 0.79 (0.55–1.13) | |
Ischemic stroke-related death | Without FSG elevation | ||||
Events | 19 | 5 | 15 | 32 | |
Person-years | 194,009 | 58,546 | 114,444 | 206,670 | |
aHR (95% CI) | 1.00 (reference) | 0.67 (0.25–1.82) | 0.76 (0.38–1.53) | 0.82 (0.45–1.50) | |
With FSG elevation | |||||
Events | 14 | 10 | 5 | 524 | |
Person-years | 146,281 | 46,952 | 80,915 | 146,282 | |
aHR (95% CI) | 1.00 (reference) | 2.02 (0.88–2.64) | 0.48 (0.17–1.35) | 1.16 (0.58–2.33) | |
Hemorrhagic stroke-related death | Without FSG elevation | ||||
Events | 25 | 2 | 15 | 22 | |
Person-years | 194,009 | 58,546 | 114,444 | 206,670 | |
aHR (95% CI) | 1.00 (reference) | — | 0.81 (0.42–1.58) | 0.59 (0.32–1.10) | |
With FSG elevation | |||||
Events | 25 | 13 | 10 | 20 | |
Person-years | 146,281 | 46,952 | 80,915 | 146,282 | |
aHR (95% CI) | 1.00 (reference) | 1.28 (0.79–3.15) | 0.61 (0.29–1.30) | 0.63 (0.34–1.18) |
*FSG elevation defined by an elevation of fasting serum glucose of more than the upper limit of 95% confidence interval for FSG change among quitters (>4.17 mg/dL)
Hazard ratio calculated by Cox proportional hazards regression analysis with adjustments for age, socioeconomic status, physical activity, alcohol consumption, body mass index, baseline fasting serum glucose, blood pressure, total cholesterol, and Charlson comorbidity index
Acronyms: FSG, fasting serum glucose; aHR, adjusted hazard ratio; CI, confidence interval
Blank cells indicate no reliable values of hazard ratios and 95% confidence intervals due to the small number of events.